LOADING
Comparing Merck & Company (MRK) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $354.8B | $166.5B |
| P/E Ratio | 116.0 | 8.0 |
| Forward P/E | 15.3 | 9.9 |
| PEG Ratio | 2.71 | 1.53 |
| EPS | $1.24 | $3.03 |
| Revenue Growth (YoY) | 5.1% | 2.3% |
| Profit Margin | 4.8% | 16.9% |
| Return on Equity | 7.0% | 18.3% |
| Dividend Yield | 2.28% | 4.57% |
| Beta | 0.23 | 0.43 |
| 52-Week High | $156.00 | $28.75 |
| 52-Week Low | $79.67 | $19.63 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AT&T Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.